Halaven

药品简介

Originator: HALAVEN by Eisai Inc. · Manufacturer: Eisai Co Ltd.. Indication & Dosage: HALAVEN (Eribulin Mesylate) is a prescription medicine used to treat metastatic or advanced breast cancer that has spread to other parts of the body and who have already received other types of anticancer medicines after the cancer has spread. HALAVEN manufactured by Eisai Co. Ltd in India. Eribulin Mesylate is given by injection under the skin as directed by the doctor. The dosage is based on patient's medical condition and response to treatment. Please Follow doctor's instructions carefully. Side Effects: The most common adverse reaction of Eribulin Mesylate are: Weakness or tiredness , hair loss, nausea , constipation. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。